xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 64733 | 12 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TLATWVGNNLED | 12 | null | 67 | 78 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3024 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 2 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 64733 | 12 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TLATWVGNNLED | 12 | null | 67 | 78 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3021 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 2 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 21480 | 13 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GNNLEDPASRDL | 12 | null | 73 | 84 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3027 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 8 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 21480 | 13 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GNNLEDPASRDL | 12 | null | 73 | 84 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3028 | 37 | Table 1 | Negative | false | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 8 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 21480 | 13 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GNNLEDPASRDL | 12 | null | 73 | 84 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3030 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 8 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 46950 | 14 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PASRDLVVNYVN | 12 | null | 79 | 90 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3034 | 37 | Table 1 | Negative | false | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 46950 | 14 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PASRDLVVNYVN | 12 | null | 79 | 90 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3033 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 71780 | 15 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VVNYVNTNVGLK | 12 | null | 85 | 96 | 10407 | P03148.3 | null | Exact Epitope | Representative selection | BCell | 3039 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 3 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 71780 | 15 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VVNYVNTNVGLK | 12 | null | 85 | 96 | 10407 | P03148.3 | null | Exact Epitope | Representative selection | BCell | 3040 | 37 | Table 1 | Negative | false | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 3 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 65476 | 16 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TNVGLKIRQLLW | 12 | null | 91 | 102 | 10407 | P03148.3 | null | Exact Epitope | Representative selection | BCell | 3046 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 2 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 65476 | 16 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TNVGLKIRQLLW | 12 | null | 91 | 102 | 10407 | P03148.3 | null | Exact Epitope | Representative selection | BCell | 3045 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 2 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 28377 | 17 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IRQLLWFHISCL | 12 | null | 97 | 108 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3051 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 2 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 28377 | 17 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IRQLLWFHISCL | 12 | null | 97 | 108 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3052 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 2 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 16114 | 18 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FHISCLTFGRET | 12 | null | 103 | 114 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3057 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 16114 | 18 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FHISCLTFGRET | 12 | null | 103 | 114 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3058 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 63665 | 19 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TFGRETVLEYLV | 12 | null | 109 | 120 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3063 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 6 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 63665 | 19 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TFGRETVLEYLV | 12 | null | 109 | 120 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3064 | 37 | Table 1 | Negative | false | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 6 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 69475 | 20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLEYLVSFGVWI | 12 | null | 115 | 126 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3070 | 37 | Table 1 | Negative | false | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 3 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 69475 | 20 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLEYLVSFGVWI | 12 | null | 115 | 126 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3069 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 3 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 57786 | 21 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SFGVWIRTPPGY | 12 | null | 121 | 132 | 10407 | AAL31780.1 | null | Exact Epitope | Not determined | BCell | 3076 | 37 | Table 1 | Negative | false | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 4 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 57786 | 21 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SFGVWIRTPPGY | 12 | null | 121 | 132 | 10407 | AAL31780.1 | null | Exact Epitope | Not determined | BCell | 3075 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 4 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 56152 | 22 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RTPPGYRPPNAP | 12 | null | 127 | 138 | 10407 | AAL31780.1 | null | Exact Epitope | Not determined | BCell | 3082 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 7 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 56152 | 22 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RTPPGYRPPNAP | 12 | null | 127 | 138 | 10407 | AAL31780.1 | null | Exact Epitope | Not determined | BCell | 3081 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 7 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 55262 | 23 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RPPNAPILSTLP | 12 | null | 133 | 144 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3088 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 6 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 55262 | 23 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RPPNAPILSTLP | 12 | null | 133 | 144 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3089 | 37 | Table 1 | Negative | false | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 6 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 27366 | 24 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILSTLPETTVVR | 12 | null | 139 | 150 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3094 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 3 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 27366 | 24 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILSTLPETTVVR | 12 | null | 139 | 150 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3095 | 37 | Table 1 | Negative | false | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 3 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 14580 | 25 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ETTVVRRRGRSP | 12 | null | 145 | 156 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3101 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 4 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 14580 | 25 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ETTVVRRRGRSP | 12 | null | 145 | 156 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3102 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 4 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 14580 | 25 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ETTVVRRRGRSP | 12 | null | 145 | 156 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3103 | 37 | Table 1 | Negative | false | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 4 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 55588 | 26 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRGRSPRRRTPS | 12 | null | 151 | 162 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3107 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 55588 | 26 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRGRSPRRRTPS | 12 | null | 151 | 162 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3108 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 55732 | 27 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRRTPSPRRRRS | 12 | null | 157 | 168 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3114 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 55732 | 27 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRRTPSPRRRRS | 12 | null | 157 | 168 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3113 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 49248 | 28 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PRRRRSQSPRRR | 12 | null | 163 | 174 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3119 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 7 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 49248 | 28 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PRRRRSQSPRRR | 12 | null | 163 | 174 | 10407 | BAF42671.1 | null | Exact Epitope | Not determined | BCell | 3120 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 7 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 52403 | 29 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QSPRRRRSQSRE | 12 | null | 171 | 182 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3125 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 52403 | 29 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QSPRRRRSQSRE | 12 | null | 171 | 182 | 10407 | CAL29866.1 | null | Exact Epitope | Not determined | BCell | 3126 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 55936 | 30 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RSQSRESQCKLG | 12 | null | null | null | 10407 | null | null | Exact Epitope | Internal Identifier-no external match available | BCell | 3131 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 8 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 55936 | 30 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RSQSRESQCKLG | 12 | null | null | null | 10407 | null | null | Exact Epitope | Internal Identifier-no external match available | BCell | 3130 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Internal Identifier-no external match available | null | 8 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 60396 | 31 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SQCKLGSVDLN | 11 | null | null | null | 10407 | null | null | Exact Epitope | Internal Identifier-no external match available | BCell | 3136 | 37 | Table 1 | Positive | true | null | 10000000 | F | 8-12 weeks | null | null | null | null | null | null | Exact match to reference information | Internal Identifier-no external match available | null | 9 |
481.xml | 481 | 2023-08-18-07:00 | 15589316 | 2,005 | Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen. | Molecular immunology | Y Lobaina; D Palenzuela; D Pichardo; V Muzio; G Guillén; J C Aguilar | 60396 | 31 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SQCKLGSVDLN | 11 | null | null | null | 10407 | null | null | Exact Epitope | Internal Identifier-no external match available | BCell | 3137 | 37 | Table 1 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Not determined | null | 9 |
482.xml | 482 | 2025-11-06-08:00 | 15451471 | 2,004 | Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2:Ig fusion protein. | Clinical immunology (Orlando, Fla.) | Yue-Dan Wang; Wei Feng Chen | 16156 | S1203 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FIAGLIAIV | 9 | null | 1,202 | 1,210 | 10002316 | P59594.1 | null | Exact Epitope | Not determined | TCell | 2943 | 48 | Figure 1A | Positive | true | null | 9606 | F | 20-23 years | DOID:2945 | 235 | null | T cell CD8+ | blood | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
482.xml | 482 | 2025-11-06-08:00 | 15451471 | 2,004 | Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2:Ig fusion protein. | Clinical immunology (Orlando, Fla.) | Yue-Dan Wang; Wei Feng Chen | 16156 | S1203 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FIAGLIAIV | 9 | null | 1,202 | 1,210 | 10002316 | P59594.1 | null | Exact Epitope | Not determined | TCell | 2964 | 47 | Figure 1B | Positive | true | null | 9606 | F | 20-23 years | DOID:2945 | 235 | null | T cell CD8+ | blood | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
484.xml | 484 | 2025-11-06-08:00 | 15449035 | 2,005 | Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma. | Cancer immunology, immunotherapy : CII | Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson | 12941 | MART-1 26-35 Analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ELAGIGILTV | 10 | null | null | null | null | null | null | Exact Epitope | null | TCell | 3236 | 73 | Figure 1 | Positive | true | null | 9606 | null | null | DOID:8923 | 235 | 235 | lymphocyte | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 8 |
484.xml | 484 | 2025-11-06-08:00 | 15449035 | 2,005 | Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma. | Cancer immunology, immunotherapy : CII | Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson | 75043 | Tyrosinase<sub>372-380</sub> | FragmentOfANaturalSequenceMolecule | Peptide from protein | YMDGTMSQV | 9 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 3237 | 73 | Figure 1 | Positive | true | null | 9606 | null | null | DOID:8923 | 235 | 235 | lymphocyte | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 1 |
484.xml | 484 | 2025-11-06-08:00 | 15449035 | 2,005 | Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma. | Cancer immunology, immunotherapy : CII | Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson | 74642 | GP100 280-9 V Analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | YLEPGPVTVP | 10 | null | null | null | null | null | null | Exact Epitope | null | TCell | 3238 | 73 | Figure 1 | Positive | true | null | 9606 | null | null | DOID:8923 | 235 | 235 | lymphocyte | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 9 |
484.xml | 484 | 2025-11-06-08:00 | 15449035 | 2,005 | Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma. | Cancer immunology, immunotherapy : CII | Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson | 27469 | GP100 209-2 M Analog | SequenceMoleculeNoNaturalSource | Peptide, no natural source | IMDQVPFSV | 9 | null | null | null | null | null | null | Exact Epitope | null | TCell | 3239 | 73 | Figure 1 | Positive | true | null | 9606 | null | null | DOID:8923 | 235 | 235 | lymphocyte | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 48237 | HA(307-319) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 306 | 318 | 11320 | P12582.1 | null | Exact Epitope | Not determined | TCell | 3243 | 69 | Figure 1C, Table 2 | Positive | true | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 4 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 48237 | HA(307-319) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 306 | 318 | 11320 | P12582.1 | null | Exact Epitope | Not determined | TCell | 3245 | 73 | Figure 1B, Table 2 | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 4 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 48237 | HA(307-319) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 306 | 318 | 11320 | P12582.1 | null | Exact Epitope | Not determined | TCell | 10326 | 83 | Table 2 | Negative | false | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 4 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 48237 | HA(307-319) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 306 | 318 | 11320 | P12582.1 | null | Exact Epitope | Not determined | TCell | 3242 | 69 | Figure 1A, Table 2 | Positive | true | null | 10000601 | null | null | null | 327 | 327 | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 4 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 48237 | HA(307-319) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 306 | 318 | 11320 | P12582.1 | null | Exact Epitope | Not determined | TCell | 10327 | 83 | Table 2 | Negative | false | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 4 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 48237 | HA(307-319) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKYVKQNTLKLAT | 13 | null | 306 | 318 | 11320 | P12582.1 | null | Exact Epitope | Not determined | TCell | 3244 | 73 | Figure 1D, Table 2 | Positive | true | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 4 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 3783 | p53(63-77) | FragmentOfANaturalSequenceMolecule | Peptide from protein | APRMEPAAPPVAPAP | 15 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 3251 | 83 | Figure 2D, Table 2 | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 1 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 3783 | p53(63-77) | FragmentOfANaturalSequenceMolecule | Peptide from protein | APRMEPAAPPVAPAP | 15 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 10328 | 69 | Figure 3C, Table 2 | Negative | false | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 1 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 3783 | p53(63-77) | FragmentOfANaturalSequenceMolecule | Peptide from protein | APRMEPAAPPVAPAP | 15 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 10329 | 73 | Figure 2D, Table 2 | Negative | false | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 1 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 3783 | p53(63-77) | FragmentOfANaturalSequenceMolecule | Peptide from protein | APRMEPAAPPVAPAP | 15 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 3248 | 69 | Figure 2C, Table 2 | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 1 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 3783 | p53(63-77) | FragmentOfANaturalSequenceMolecule | Peptide from protein | APRMEPAAPPVAPAP | 15 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 10330 | 73 | Table 2 | Negative | false | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 1 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 10337 | 69 | Figure 5 | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Not determined | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 3254 | 83 | Figure 3F, Table 2 | Positive | true | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 3256 | 73 | Figure 1, Table 2 | Negative | false | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 3252 | 69 | Figure 2E, Table 2 | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 3283 | 69 | Figure 6 | Positive | true | null | 9606 | null | null | ONTIE:0003423 | 327 | null | T cell | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 7212 | 83 | Figure 4C | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Not determined | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 3284 | 73 | Figure 6 | Positive | true | null | 9606 | null | null | ONTIE:0003423 | 327 | null | T cell | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 7211 | 69 | Figure 4B | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Not determined | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 3253 | 69 | Figure 3E, Table 2 | Positive | true | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 19613 | p53(108-122) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFRLGFLHSGTAKSV | 15 | null | 108 | 122 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 3255 | 73 | Figure 2F, Table 2 | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 45282 | p53(29-43) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NNVLSPLPSQAMDDL | 15 | null | 29 | 43 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 10332 | 69 | Figure 2A, Table 2 | Negative | false | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 9 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 45282 | p53(29-43) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NNVLSPLPSQAMDDL | 15 | null | 29 | 43 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 10336 | 73 | Table 2 | Negative | false | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 9 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 45282 | p53(29-43) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NNVLSPLPSQAMDDL | 15 | null | 29 | 43 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 10334 | 69 | Figure 3A, Table 2 | Negative | false | null | 10000610 | null | null | null | 341 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 9 |
485.xml | 485 | 2025-11-06-08:00 | 15449037 | 2,005 | Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53. | Cancer immunology, immunotherapy : CII | José Manuel Rojas; Stephanie E B McArdle; Roger B V Horton; Matthew Bell; Shahid Mian; Geng Li; Selman A Ali; Robert C Rees | 45282 | p53(29-43) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NNVLSPLPSQAMDDL | 15 | null | 29 | 43 | 9606 | P04637.4 | null | Exact Epitope | Not determined | TCell | 10333 | 83 | Figure 2B, Table 2 | Positive | true | null | 10000601 | null | null | null | 327 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 9 |
486.xml | 486 | 2025-11-06-08:00 | 15542798 | 2,004 | Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Craig L Slingluff; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jayashree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill | 7497 | DAEK | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DAEKSDICTDEY | 12 | null | null | null | null | null | null | Epitope containing region/antigenic site | null | TCell | 3295 | 48 | Figures 4A and 4B | Positive | true | null | 9606 | null | null | DOID:8923 | 233 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
486.xml | 486 | 2025-11-06-08:00 | 15542798 | 2,004 | Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Craig L Slingluff; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jayashree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill | 74638 | YLE | FragmentOfANaturalSequenceMolecule | Peptide from protein | YLEPGPVTA | 9 | null | 280 | 288 | 9606 | P40967.2 | null | Exact Epitope | Not determined | TCell | 3408 | 48 | Figures 4A and 4B | Positive | true | null | 9606 | null | null | DOID:8923 | 235 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 6 |
486.xml | 486 | 2025-11-06-08:00 | 15542798 | 2,004 | Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Craig L Slingluff; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jayashree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill | 75043 | YMD | FragmentOfANaturalSequenceMolecule | Peptide from protein | YMDGTMSQV | 9 | null | null | null | 9606 | null | null | Exact Epitope | Internal Identifier-no external match available | TCell | 3412 | 48 | Figures 4A and 4B | Positive | true | null | 9606 | null | null | DOID:8923 | 235 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 1 |
489.xml | 489 | 2023-08-18-07:00 | 15501759 | 2,004 | Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. | Infection and immunity | Fabien Brossier; Martine Lévy; Annie Landier; Pierre Lafaye; Michèle Mock | 8176 | Domain 4 amino acids 608-735 | FragmentOfANaturalSequenceMolecule | Peptide from protein | DESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG | 128 | null | 637 | 764 | 1392 | P13423.2 | null | Epitope containing region/antigenic site | Not determined | BCell | 1325078 | 37 | Text | Positive | true | null | 10000026 | null | null | null | null | null | null | null | null | Not determined | Not determined | null | 1 |
489.xml | 489 | 2023-08-18-07:00 | 15501759 | 2,004 | Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. | Infection and immunity | Fabien Brossier; Martine Lévy; Annie Landier; Pierre Lafaye; Michèle Mock | 8176 | Domain 4 amino acids 608-735 | FragmentOfANaturalSequenceMolecule | Peptide from protein | DESVVKEAHREVINSSTEGLLLNIDKDIRKILSGYIVEIEDTEGLKEVINDRYDMLNISSLRQDGKTFIDFKKYNDKLPLYISNPNYKVNVYAVTKENTIINPSENGDTSTNGIKKILIFSKKGYEIG | 128 | null | 637 | 764 | 1392 | P13423.2 | null | Epitope containing region/antigenic site | Not determined | BCell | 1325079 | 629 | Figure 5 | Positive | true | null | 10000026 | null | null | null | null | null | null | null | null | Not determined | Not determined | null | 1 |
492.xml | 492 | 2025-11-06-08:00 | 15069731 | 2,004 | Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice. | World journal of gastroenterology : WJG | Tong-Dong Shi; Yu-Zhang Wu; Zheng-Cai Jia; Wei Zhou; Li-Yun Zou | 16833 | HBcAg 18-27 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLPSDFFPSV | 10 | null | 18 | 27 | 10407 | P03149.1 | null | Exact Epitope | Representative selection | TCell | 3273 | 48 | Table 1 | Positive | true | null | 10000582 | null | 6-8 weeks | null | 235 | null | T cell CD8+ | spleen | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
492.xml | 492 | 2025-11-06-08:00 | 15069731 | 2,004 | Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice. | World journal of gastroenterology : WJG | Tong-Dong Shi; Yu-Zhang Wu; Zheng-Cai Jia; Wei Zhou; Li-Yun Zou | 16833 | HBcAg 18-27 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLPSDFFPSV | 10 | null | 18 | 27 | 10407 | P03149.1 | null | Exact Epitope | Representative selection | TCell | 1855358 | 47 | Figure 1 | Positive | true | null | 10000582 | null | 6-8 weeks | null | 235 | null | T cell CD8+ | spleen | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
492.xml | 492 | 2025-11-06-08:00 | 15069731 | 2,004 | Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice. | World journal of gastroenterology : WJG | Tong-Dong Shi; Yu-Zhang Wu; Zheng-Cai Jia; Wei Zhou; Li-Yun Zou | 16833 | HBcAg 18-27 | FragmentOfANaturalSequenceMolecule | Peptide from protein | FLPSDFFPSV | 10 | null | 18 | 27 | 10407 | P03149.1 | null | Exact Epitope | Representative selection | TCell | 1855357 | 67 | Table 2 | Positive | true | null | 10000582 | null | 6-8 weeks | null | 235 | null | T cell CD8+ | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 9 |
493.xml | 493 | 2025-11-06-08:00 | 15388261 | 2,004 | Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer. | Immunology letters | Yasuto Akiyama; Kiyotaka Kuzushima; Tatsuya Tsurumi; Ken Yamaguchi | 52886 | CMV pp65 (341-349) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYDPVAALF | 9 | null | 341 | 349 | 10359 | YP_002608275.1 | null | Exact Epitope | Representative selection | TCell | 3291 | 48 | Table 1 | Positive | true | null | 9606 | null | null | ONTIE:0003423 | 237 | null | T cell CD8+ | blood | Short Term Restimulated | Exact match to reference information | Representative selection | null | 3 |
493.xml | 493 | 2025-11-06-08:00 | 15388261 | 2,004 | Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer. | Immunology letters | Yasuto Akiyama; Kiyotaka Kuzushima; Tatsuya Tsurumi; Ken Yamaguchi | 52886 | CMV pp65 (341-349) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYDPVAALF | 9 | null | 341 | 349 | 10359 | YP_002608275.1 | null | Exact Epitope | Representative selection | TCell | 3289 | 67 | Table 1, and figure 1 | Positive | true | null | 9606 | null | null | ONTIE:0003423 | 237 | null | T cell CD8+ | blood | Short Term Restimulated | Exact match to reference information | Representative selection | null | 3 |
493.xml | 493 | 2025-11-06-08:00 | 15388261 | 2,004 | Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer. | Immunology letters | Yasuto Akiyama; Kiyotaka Kuzushima; Tatsuya Tsurumi; Ken Yamaguchi | 52886 | CMV pp65 (341-349) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYDPVAALF | 9 | null | 341 | 349 | 10359 | YP_002608275.1 | null | Exact Epitope | Representative selection | TCell | 3290 | 47 | Table 1 and figure 3 | Positive | true | null | 9606 | null | null | ONTIE:0003423 | 237 | null | T cell CD8+ | blood | Short Term Restimulated | Exact match to reference information | Representative selection | null | 3 |
494.xml | 494 | 2025-11-06-08:00 | 15100298 | 2,004 | Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity. | Journal of immunology (Baltimore, Md. : 1950) | Nicole L La Gruta; Stephen J Turner; Peter C Doherty | 4602 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1007597 | 53 | Figures 5 and 6, Figures 1, 2, 3, 4, 5, 7, 8 | Positive | true | null | 10000067 | F | 6-8 weeks | DOID:8469 | 172 | null | T cell CD8+ | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
494.xml | 494 | 2025-11-06-08:00 | 15100298 | 2,004 | Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity. | Journal of immunology (Baltimore, Md. : 1950) | Nicole L La Gruta; Stephen J Turner; Peter C Doherty | 61151 | PA 224-233 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SSLENFRAYV | 10 | null | 224 | 233 | 211044 | null | null | Exact Epitope | Not determined | TCell | 1007610 | 53 | Figures 5 and 6, Figures 1, 2, 3, 4, 5, 7, 8 | Positive | true | null | 10000067 | F | 6-8 weeks | DOID:8469 | 172 | null | T cell CD8+ | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
495.xml | 495 | 2023-08-18-07:00 | 15713683 | 2,005 | Structural investigation of Borrelia burgdorferi OspB, a bactericidal Fab target. | The Journal of biological chemistry | Michael Becker; Jonas Bunikis; Barbara D Lade; John J Dunn; Alan G Barbour; Catherine L Lawson | 77380 | OspB - H6831 Fab epitope | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | G231, S232, N233, A250, D251, S252, K253, K254, N272, T273, A274, G275, T276 | null | null | 139 | P17739.1 | G231, S232, N233, A250, D251, S252, K253, K254, N272, T273, A274, G275, T276 | Epitope containing region/antigenic site | Author provided Identifier | BCell | 3294 | 436 | Figure 3, Table 1 | Positive | true | 2.6 | 10000000 | null | null | null | null | null | null | null | null | Exact match to reference information | Exact match to reference information | null | 5 |
496.xml | 496 | 2023-08-18-07:00 | 9501911 | 1,998 | Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. | Nature structural biology | R Celikel; K I Varughese; Madhusudan; A Yoshioka; J Ware; Z M Ruggeri | 132127 | NMC-4 epitope on vWF A1 domain | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | P1390, Q1391, R1392, S1394, R1395, N1396, F1397, V1398, R1399, N1421, K1423, Q1424, L1427 | null | null | 9606 | P04275.3 | P627, Q628, R629, S631, R632, N633, F634, V635, R636, N658, K660, Q661, L664 | Exact Epitope | Author provided Identifier | BCell | 1772912 | 34 | Text p. 191 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
496.xml | 496 | 2023-08-18-07:00 | 9501911 | 1,998 | Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. | Nature structural biology | R Celikel; K I Varughese; Madhusudan; A Yoshioka; J Ware; Z M Ruggeri | 132127 | NMC-4 epitope on vWF A1 domain | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | P1390, Q1391, R1392, S1394, R1395, N1396, F1397, V1398, R1399, N1421, K1423, Q1424, L1427 | null | null | 9606 | P04275.3 | P627, Q628, R629, S631, R632, N633, F634, V635, R636, N658, K660, Q661, L664 | Exact Epitope | Author provided Identifier | BCell | 1708124 | 436 | Figures 1, 2, 3, 4 and Table 1 and PDB 1OAK | Positive | true | 2.2 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
497.xml | 497 | 2023-08-18-07:00 | 11342547 | 2,001 | Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. | The Journal of biological chemistry | A Desmyter; K Decanniere; S Muyldermans; L Wyns | 241578 | CA2 - cAb-CA05 VHH | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | P46, L47, S48, V49, S50, Y51, D52, D179, R181, G182, L184, P185, E186 | null | null | 9913 | null | P46, L47, S48, V49, S50, Y51, D52, D180, R182, G183, L185, P186, E187 | Exact Epitope | Internal Identifier-no external match available | BCell | 1491564 | 436 | Table II | Positive | true | 3.5 | 9838 | null | null | null | null | null | null | null | null | Internal Identifier-no external match available | Internal Identifier-no external match available | null | 9 |
498.xml | 498 | 2023-08-18-07:00 | 7994573 | 1,994 | The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. | Structure (London, England : 1993) | R L Malby; W R Tulip; V R Harley; J L McKimm-Breschkin; W G Laver; R G Webster; P M Colman | 77552 | NC10 Fab epitope on N9 neuraminidase | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | P330, N331, D332, P333, T334, Y342, G344, N345, I367, I369, A370, S371, S373, N400, T401, W403 | null | null | 11484 | P05803.1 | P328, N329, D330, P331, T332, Y341, G343, N344, I366, I368, A369, S370, S372, N400, T401, W403 | Partial Epitope | Representative selection | BCell | 3298 | 436 | Figures 2, 3, 4, 5, 6, Table 3, 4 and PDB 1NMB | Positive | true | 2.2 | 10000000 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 34966 | LASLVLCGV | FragmentOfANaturalSequenceMolecule | Peptide from protein | LASLVLCGV | 9 | null | 4 | 12 | 9606 | AAA61139.1 | null | Exact Epitope | Author provided Identifier | MhcBinding | 1852503 | 185 | Figure 2 and table II | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 37805 | LLSLVLCGV | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LLSLVLCGV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1852508 | 185 | Figure 2 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 40436 | LVLCGVSLL | FragmentOfANaturalSequenceMolecule | Peptide from protein | LVLCGVSLL | 9 | null | 7 | 15 | 9606 | AAA61139.1 | null | Exact Epitope | Author provided Identifier | MhcBinding | 1852510 | 185 | Figure 2 and table II | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 37464 | Z95 LLLCGVSLV | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LLLCGVSLV | 9 | null | null | null | null | null | null | Exact Epitope | null | TCell | 1852622 | 67 | Figure 3 | Negative | false | null | 10000576 | null | 6-12 weeks | null | 143 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 8 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 37464 | Z95 LLLCGVSLV | SequenceMoleculeNoNaturalSource | Peptide, no natural source | LLLCGVSLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1852522 | 185 | Figure 2 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 150436 | MDLILINSL | FragmentOfANaturalSequenceMolecule | Peptide from protein | MDLILINSL | 9 | null | 24 | 32 | 9606 | AAA61139.1 | null | Exact Epitope | Author provided Identifier | MhcBinding | 1852523 | 185 | Figure 2 and table II | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 41972 | MLILILNSV | SequenceMoleculeNoNaturalSource | Peptide, no natural source | MLILILNSV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1852524 | 185 | Figure 2 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 9667 | DPLEVTQDV | FragmentOfANaturalSequenceMolecule | Peptide from protein | DPLEVTQDV | 9 | null | 70 | 78 | 9606 | AAA61139.1 | null | Exact Epitope | Author provided Identifier | MhcBinding | 1852525 | 185 | Figure 2 and table II | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
500.xml | 500 | 2025-11-06-08:00 | 15069689 | 2,004 | Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2. | International journal of cancer. Journal international du cancer | Judith M Ramage; Rachael Metheringham; Andrew Conn; Ian Spendlove; Robert S Moss; Daniel T Patton; J Clifford Murray; Robert C Rees; Lindy G Durrant | 9165 | DLLEVTQDV | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLLEVTQDV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1852526 | 185 | Figure 2 | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.